Novocure Ltd (NVCR) stock news · rev $655.4M
Novocure Ltd (NVCR) is a medical devices company listed on US.
This NVCR news page leads with what Novocure Ltd filed — not a scraped headline mill.
No cached 8-K sentence for NVCR yet. We will not pad this page with generic market recap.
Latest reported NVCR revenue for 2025-12-31 was $655.4M. Net income was -$136.2M. Revenue was up 400.3% from 2022-09-30 to 2025-12-31. NVCR currently screens at market cap $1.99B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the NVCR stock page; for the tape open the quote page.
NVCR stock news FAQ
What are NVCR's latest revenue and net income?
Latest cached Novocure Ltd (NVCR) revenue for Dec 31, 2025 was $655.4M. Net income was -$136.2M. Statements: https://lician.com/financials/nvcr
How did NVCR revenue change from the prior cached period?
Cached Novocure Ltd (NVCR) revenue was up 400.3% from $131.0M (Sep 30, 2022) to $655.4M (Dec 31, 2025). Statements: https://lician.com/financials/nvcr
What is NVCR's market cap?
Novocure Ltd (NVCR) market cap is $1.99B on the latest cached fundamentals snapshot.
What kind of company is NVCR?
Novocure Ltd (NVCR) is a medical devices company listed on US.
Where is NVCR stock news listed?
Cached stock news for Novocure Ltd (NVCR) is listed at https://lician.com/news/nvcr. Filings: https://lician.com/sec/nvcr
Not investment advice.